The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Chemerin Is a Novel Adipokine Associated with Obesity and Metabolic Syndrome
Abstract
Soluble protein hormones are key regulators of a number of metabolic processes, including food intake and insulin sensitivity. We have used a signal sequence trap to identify genes that encode secreted or membrane-bound proteins in Psammomys obesus, an animal model of obesity and type 2 diabetes (T2D). Using this signal sequence trap, we identified the chemokine chemerin as being a novel adipokine. Gene expression of chemerin and its receptor, chemokine-like receptor 1 (CMKLR1), was significantly higher in adipose tissue of obese and type 2 diabetic P. obesus compared with lean, normoglycemic P. obesus. Fractionation of P. obesus adipose tissue confirmed that chemerin was predominantly expressed in adipocytes, whereas CMKLR1 was expressed in both adipocytes and stromal-vascular cells of adipose tissue. In 3T3-L1 adipocytes, chemerin was markedly induced during differentiation, whereas CMKLR1 was down-regulated during differentiation. Serum chemerin levels were measured by ELISA in human plasma samples from 114 subjects with T2D and 142 normal glucose tolerant controls. Plasma chemerin levels were not significantly different between subjects with T2D and normal controls. However, in normal glucose tolerant subjects, plasma chemerin levels were significantly associated with body mass index, circulating triglycerides, and blood pressure. Here we report, for the first time, that chemerin is an adipokine, and circulating levels of chemerin are associated with several key aspects of metabolic syndrome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041
Xu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319451 · Cited by 6,760
Eckel, R. H., Alberti, K., Grundy, S. M., & Zimmet, P. Z. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61794-3 · Cited by 6,295
Self-citationGrundy, S. M., Brewer, H. B., Cleeman, J. I., Smith, S. C., & Lenfant, C. (2004) · Circulation · doi:10.1161/01.cir.0000111245.75752.c6 · Cited by 5,982
Eckel, R. H., Grundy, S. M., & Zimmet, P. Z. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66378-7 · Cited by 5,550
Self-citationSubcutaneous and visceral adipose tissue: their relation to the metabolic syndrome
Wajchenberg, B. L. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.6.0415 · Cited by 2,961
Adipocytes as regulators of energy balance and glucose homeostasis
Rosen, E. D., & Spiegelman, B. M. (2006) · Nature · doi:10.1038/nature05483 · Cited by 2,170 · cited 2×
“These macrophages secrete other proinflammatory cytokines such as TNF- and IL-6, which can act in a paracrine fashion to affect insulin sensitivity of adipocytes or as endocrine factors to affect insulin sensitivity of distal tissues, such as skeletal muscle and liver (5).”
BackgroundSerum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes
Yang, Q., Graham, T. E., Mody, N., Preitner, F., Peroni, O. D., Zabolotny, J. M., Kotani, K., Quadro, L., & Kahn, B. B. (2005) · Nature · doi:10.1038/nature03711 · Cited by 2,086
Retinol-Binding Protein 4 and Insulin Resistance in Lean, Obese, and Diabetic Subjects
Graham, T. E., Yang, Q., Blüher, M., Hammarstedt, A., Ciaraldi, T. P., Henry, R. R., Wason, C. J., Oberbach, A., Jansson, P.-A., Smith, U., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054862 · Cited by 1,319
The endocrine function of adipose tissue: an update
Ronti, T., Lupattelli, G., & Mannarino, E. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02474.x · Cited by 902
Wittamer, V., Franssen, J.-D., Vulcano, M., Mirjolet, J.-F., Le Poul, E., Migeotte, I., Brézillon, S., Tyldesley, R., Blanpain, C., Detheux, M., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030382 · Cited by 888
Adiponectin as a Biomarker of the Metabolic Syndrome
Ryo, M., Nakamura, T., Kihara, S., Kumada, M., Shibazaki, S., Takahashi, M., Nagai, M., Matsuzawa, Y., & Funahashi, T. (2004) · Circulation Journal · doi:10.1253/circj.68.975 · Cited by 767
Adiponectin – a key adipokine in the metabolic syndrome
Whitehead, J. P., Richards, A. A., Hickman, I. J., Macdonald, G. A., & Prins, J. B. (2006) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2005.00510.x · Cited by 644
MacDougald, O. A., Hwang, C. S., Fan, H., & Lane, M. D. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9034 · Cited by 518
Impaired retinal function and vitamin A availability in mice lacking retinol‐binding protein
Quadro, L., Blaner, W. S., Salchow, D. J., Vogel, S., Piantedosi, R., Gouras, P., Freeman, S., Cosma, M. P., Colantuoni, V., & Gottesman, M. E. (1999) · The EMBO Journal · doi:10.1093/emboj/18.17.4633 · Cited by 506
Maffei, M., Fei, H., Lee, G. H., Dani, C., Leroy, P., Zhang, Y., Proenca, R., Negrel, R., Ailhaud, G., & Friedman, J. M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.15.6957 · Cited by 465
Chemerin Activation by Serine Proteases of the Coagulation, Fibrinolytic, and Inflammatory Cascades
Zabel, B. A., Allen, S. J., Kulig, P., Allen, J. A., Cichy, J., Handel, T. M., & Butcher, E. C. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504868200 · Cited by 369
Karlsson, C., Lindell, K., Ottosson, M., Sjöström, L., Carlsson, B., & Carlsson, L. M. S. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.11.5276 · Cited by 322
Tazarotene-induced Gene 2 (TIG2), a Novel Retinoid-Responsive Gene in Skin
Nagpal, S., Patel, S., Jacobe, H., DiSepio, D., Ghosn, C., Malhotra, M., Teng, M., Duvic, M., & Chandraratna, R. A. S. (1997) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12276660 · Cited by 299
Vermi, W., Riboldi, E., Wittamer, V., Gentili, F., Luini, W., Marrelli, S., Vecchi, A., Franssen, J.-D., Communi, D., Massardi, L., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041310 · Cited by 289
Zabel, B. A., Silverio, A. M., & Butcher, E. C. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.1.244 · Cited by 264
A Novel Pathway to the Manifestations of Metabolic Syndrome
Sonnenberg, G. E., Krakower, G. R., & Kissebah, A. H. (2004) · Obesity Research · doi:10.1038/oby.2004.24 · Cited by 257
Neutrophil-Mediated Maturation of Chemerin: A Link between Innate and Adaptive Immunity
Wittamer, V., Bondue, B., Guillabert, A., Vassart, G., Parmentier, M., & Communi, D. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.1.487 · Cited by 248
Dowse, G. K., Zimmet, P. Z., Gareeboo, H., Alberti, K. G. M. M., Tuomilehto, J., Finch, C. F., Chitson, P., & Tulsidas, H. (1991) · Diabetes Care · doi:10.2337/diacare.14.4.271 · Cited by 233
Self-citationChemokine receptor internalization and intracellular trafficking
Neel, N. F., Schutyser, E., Sai, J., Fan, G.-H., & Richmond, A. (2005) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.05.008 · Cited by 226
High Expression of Complement Components in Omental Adipose Tissue in Obese Men
Gabrielsson, B. G., Johansson, J. M., Lönn, M., Jernås, M., Olbers, T., Peltonen, M., Larsson, I., Lönn, L., Sjöström, L., Carlsson, B., et al. (2003) · Obesity Research · doi:10.1038/oby.2003.100 · Cited by 218
High Prevalence of NIDDM and Impaired Glucose Tolerance in Indian, Creole, and Chinese Mauritians
Dowse, G. K., Gareeboo, H., Zimmet, P. Z., Alberti, K. G. M. M., Tuomilehto, J., Fareed, D., Brissonnette, L. G., Finch, C. F., & For the Mauritius Noncommunicable Disease Study Group (1990) · Diabetes · doi:10.2337/diab.39.3.390 · Cited by 200
Self-citationQUINN, L., STRAITBODEY, L., ANDERSON, B., ARGILES, J., & HAVEL, P. (2005) · Cell Biology International · doi:10.1016/j.cellbi.2005.02.005 · Cited by 199
Karlsson, C. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.11.3925 · Cited by 196
Influence of TNF-α and IL-6 infusions on insulin sensitivity and expression of IL-18 in humans
Krogh-Madsen, R., Plomgaard, P., Møller, K., Mittendorfer, B., & Pedersen, B. K. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00471.2005 · Cited by 180
Chemoattractants, extracellular proteases, and the integrated host defense response
Zabel, B. A., Zuniga, L. A., Ohyama, T., Allen, S. J., Cichy, J., Handel, T. M., & Butcher, E. C. (2006) · Experimental Hematology · doi:10.1016/j.exphem.2006.05.003 · Cited by 153
Alterations of the classic pathway of complement in adipose tissue of obesity and insulin resistance
Zhang, J., Wright, W. S., Bernlohr, D., Cushman, S. W., & Chen, X. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00664.2006 · Cited by 104
Characterization of Obesity Phenotypesin Psammomys Obesus (Israeli Sand Rats)
Walder, K. R., Fahey, R. P., Morton, G., Zimmet, P., & Collier, G. R. (2000) · Journal of Diabetes Research · doi:10.1155/edr.2000.177 · Cited by 55
Self-citationMaintenance of the postabsorptive plasma glucose concentration: insulin or insulin plus glucagon?
Raju, B., & Cryer, P. E. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00460.2004 · Cited by 46
Mårtensson, U. E. A., Bristulf, J., Owman, C., & Olde, B. (2005) · Gene · doi:10.1016/j.gene.2005.02.004 · Cited by 18
Cited by
Adipose tissue inflammation and metabolic dysfunction in obesity
Kawai, T., Autieri, M. V., & Scalia, R. (2021) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00379.2020 · Cited by 1,947
Metabolic Syndrome: Updates on Pathophysiology and Management in 2021
Fahed, G., Aoun, L., Bou Zerdan, M., Allam, S., Bou Zerdan, M., Bouferraa, Y., & Assi, H. I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020786 · Cited by 1,441
Klöting, N., Fasshauer, M., Dietrich, A., Kovacs, P., Schön, M. R., Kern, M., Stumvoll, M., & Blüher, M. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00586.2009 · Cited by 856
“Increased circulating concentrations of Nampt (35), chemerin (7), progranulin (49), and fetuin-A (37) have been shown to be associated with either insulin resistance, obesity, or both.”
BackgroundMetabolic Syndrome and Insulin Resistance: Underlying Causes and Modification by Exercise Training
Roberts, C. K., Hevener, A. L., & Barnard, R. J. (2013) · Comprehensive Physiology · doi:10.1002/cphy.c110062 · Cited by 831
Adipokines and Insulin Resistance
Rabe, K., Lehrke, M., Parhofer, K. G., & Broedl, U. C. (2008) · Molecular Medicine · doi:10.2119/2008-00058.rabe · Cited by 808
Metadata
- Authors
- Bozaoglu, K., Bolton, K., McMillan, J., Zimmet, P., Jowett, J., Collier, G., Walder, K., & Segal, D.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2007-10-01
- Volume
- 148
- Issue
- 10
- Pages
- 4687-4694
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2119773094
- Cited by
- 858
- References
- 35
- FWCI
- 14.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.